Real Medvi Weight Loss Success Stories and Patient Reviews

Last updated: October 13, 2026

Quick Answer: MEDVi is a telehealth weight-loss platform that prescribes compounded GLP-1 medications, primarily semaglutide and tirzepatide, combined with clinical support across 49 U.S. states. Based on more than 13,000 Trustpilot reviews and a 4.4 out of 5 average rating as of 2026, most patients report meaningful weight loss, attentive medical staff, and a smooth telehealth experience, making it one of the more credible GLP-1 telehealth programs available today. [4]

---

Key Takeaways

• MEDVi is a licensed telehealth platform founded in 2023 that pairs compounded GLP-1 prescriptions with ongoing clinical support.
• The program reports average weight loss of 15 to 20 percent of body weight, with typical progress of 1 to 2 pounds per week after the initial four weeks. [2][6]
• Real patient stories on MEDVi’s site describe losses ranging from 42 pounds in 4 months to 119 pounds in 13 months. [3]
• A Reddit user reported losing approximately 45 pounds over 10 months, describing results as “better than I expected.” [1]
• Trustpilot reviewers consistently praise MEDVi’s medical staff, easy onboarding, and clear treatment plans. [4]
• The most common complaints involve billing, cancellation processes, and medication delivery delays rather than clinical care itself. [9]
• MEDVi is best suited for adults with a BMI of 27 or higher who want medically supervised GLP-1 therapy without navigating traditional insurance.
• Start your MEDVi weight loss journey today if you are ready for a structured, provider-guided program.

---

What Is MEDVi Weight Loss and How Does It Work

MEDVi is a virtual healthcare platform founded in 2023 that connects patients with licensed providers who prescribe compounded GLP-1 medications, primarily semaglutide and tirzepatide, as part of a structured, medically supervised weight-loss program. [8] The platform operates across 49 U.S. states and positions itself not just as a prescription service but as a relationship-based program with regular clinical touchpoints. [2]

Here is how the process works from start to finish:

1. Complete an online health intake, You answer questions about your medical history, current weight, and health goals.
2. Provider review, A licensed clinician reviews your intake and determines whether GLP-1 therapy is appropriate for you.
3. Prescription and delivery, If approved, compounded semaglutide or tirzepatide is shipped directly to your home.
4. Ongoing clinical support, You receive regular virtual check-ins, access to your care team, and educational resources to support lifestyle changes. [2]

MEDVi’s program materials state that patients typically lose 15 to 20 percent of their body weight when they combine GLP-1 therapy with diet and exercise guidance, with a pace of roughly 1 to 2 pounds per week after the first four weeks. [6]

To understand how GLP-1 medications work at a biological level, see this detailed explanation of GLP-1 transformation and what it really does to your body.

---

Medvi Weight Loss Reviews From Real Patients

The most compelling evidence for any weight-loss program comes from the people who have actually used it. Based on medvi weight loss reviews across Trustpilot, Reddit, and MEDVi’s own testimonial pages, the picture is largely positive, with some important nuances.

What real patients are saying:

• A Reddit user who used MEDVi for 10 months reported losing approximately 45 pounds, calling the results “better than I expected” and emphasizing that progress was sustained rather than a short-term spike. [1]
• One named patient on MEDVi’s success page lost 119 pounds in 13 months and was able to discontinue blood-pressure medication, describing the program as having “saved my life.” [3]
• Another patient lost 48 pounds in 5 months and reported a 17 percent increase in muscle mass and a 55 percent improvement in sleep quality. [3]
• A third patient lost 42 pounds in 4 months, crediting GLP-1 medication and MEDVi’s support structure for a “metabolic reset” after years of failed dieting. [3]
• MEDVi’s European-focused platform features patients reporting losses of 14 to 22 kilograms over four to seven months, with many describing it as “the first thing that actually worked.” [5]

On Trustpilot, reviewers frequently highlight the quality of MEDVi’s medical staff, the ease of scheduling virtual appointments, and the clarity of treatment plans as standout positives. [4] Many describe feeling genuinely supported throughout their journey and note that providers take time to answer questions rather than rushing through consultations. [4]

For additional patient perspectives on compounded GLP-1 medications, read these compounded semaglutide reviews and real patient stories.

Explore MEDVi’s GLP-1 program and see if you qualify based on your health profile.

---

Does MEDVi Weight Loss Actually Work: Scientific Evidence

GLP-1 receptor agonists like semaglutide and tirzepatide have strong clinical backing. MEDVi’s program is built on this foundation, which gives it credibility that purely behavioral or supplement-based programs lack.

Key evidence points:

• Semaglutide (the active compound in Wegovy) demonstrated average weight loss of approximately 15 percent of body weight in major clinical trials when combined with lifestyle intervention, according to published research.
• Tirzepatide (the active compound in Zepbound and Mounjaro) showed even higher average weight loss in trials, with some participants losing more than 20 percent of body weight.
• MEDVi’s own program data aligns with these clinical benchmarks, reporting 15 to 20 percent average body weight loss for program participants. [2][6]

Important caveat: MEDVi uses compounded versions of these medications, not the branded FDA-approved drugs. Compounded formulations are not FDA-approved as finished drug products, though the active ingredients themselves are well-studied. Results can vary based on compounding quality, dosing adherence, and individual metabolic response.

For a broader look at how GLP-1 drugs compare, see this complete 2026 guide to GLP-1 medications for weight loss.

---

MEDVi Weight Loss Cost and Pricing Options

MEDVi’s pricing is structured around monthly subscription plans that include both the medication and clinical support. The platform is designed for patients who want GLP-1 therapy without relying on traditional insurance, which typically does not cover weight-loss medications.

General pricing structure:

• Compounded semaglutide programs are generally priced lower than branded Wegovy or Ozempic, making MEDVi a more accessible entry point.
• Tirzepatide-based programs tend to cost more than semaglutide options, reflecting the higher cost of the active compound.
• MEDVi offers subscription-based billing, which means charges recur monthly unless you cancel.

For a detailed breakdown of MEDVi’s tirzepatide pricing, see the MEDVi tirzepatide monthly cost guide.

Choose MEDVi if: You want a structured, medically supervised program at a lower price point than branded GLP-1 drugs and do not have insurance coverage for weight-loss medications.

Check current MEDVi pricing and program options here.

---

MEDVi Weight Loss vs Other Weight Loss Programs: A Comparison

MEDVi competes in a crowded telehealth GLP-1 market alongside platforms like Hims, Ro, and Noom Med. Here is how they compare across the dimensions that matter most to patients.

Feature	MEDVi	Hims	Branded GLP-1 (Wegovy/Zepbound)
Medication Type	Compounded semaglutide / tirzepatide	Compounded semaglutide	FDA-approved branded drugs
Clinical Support	Ongoing virtual care team	Async provider access	Varies by prescriber
Insurance Required	No	No	Often required for coverage
State Availability	49 states	Most U.S. states	Nationwide (in-person)
Trustpilot Rating	4.4/5 (13,000+ reviews)	Varies	N/A (drug, not platform)

For a full breakdown of Hims’s weight-loss program, see the Hims weight loss review and the Hims weight loss cost guide.

---

Real Medvi Weight Loss Success Stories and Patient Reviews: Before and After Highlights

The most powerful medvi weight loss reviews come from patients who share specific numbers and personal context. These are not vague endorsements, they describe real timelines and measurable outcomes.

Named success stories from MEDVi’s platform: [3][7]

• Patient A: Lost 88 pounds and described the program as enabling a “metabolic reset” after years of struggling with conventional diets. Credits GLP-1 medication and MEDVi’s provider support equally.
• Patient B: Lost 119 pounds in 13 months. Discontinued blood-pressure medication under physician guidance. Said the program “saved my life.”
• Patient C: Lost 48 pounds in 5 months with a reported 17 percent gain in lean muscle and 55 percent improvement in sleep quality.
• Patient D: Lost 42 pounds in 4 months, describing the experience as “finally feeling in control of my body for the first time in years.”

From MEDVi’s European platform: [5]

• 19 kg lost in 5 months
• 14 kg lost in 4 months
• 22 kg lost in 7 months

From Reddit: A user documented 45 pounds of loss over 10 months, noting that results built gradually rather than peaking early and fading. [1]

These outcomes reflect a real range. Not everyone loses 100+ pounds, but double-digit weight loss over a 4 to 7 month period appears achievable for many patients who follow the program consistently.

Start your own MEDVi success story today.

---

MEDVi Weight Loss Side Effects and Safety Concerns

GLP-1 medications are well-tolerated by most patients, but they do carry a known side-effect profile that anyone considering MEDVi should understand before starting.

Common side effects associated with semaglutide and tirzepatide:

• Nausea (most common, especially in the first few weeks)
• Vomiting
• Diarrhea or constipation
• Fatigue
• Reduced appetite (this is the intended mechanism, not a side effect per se)

Less common but serious concerns:

• Pancreatitis (rare but documented in GLP-1 clinical literature)
• Gallbladder issues
• Thyroid concerns (patients with a personal or family history of medullary thyroid carcinoma should not use GLP-1 medications)

MEDVi’s clinical team screens patients during intake to identify contraindications. The platform’s virtual care model means patients can flag side effects quickly and have dosing adjusted without waiting for an in-person appointment. [2]

For a detailed look at how GLP-1 drugs affect the body, see this guide on GLP-1 shots explained for weight loss and diabetes.

---

Who Is MEDVi Weight Loss Good For and Who Should Not Use It

MEDVi is a strong fit for a specific type of patient. Knowing whether you fall into that group saves time and money.

MEDVi is a good fit if you:

• Have a BMI of 27 or higher (with at least one weight-related health condition) or a BMI of 30 or higher
• Want GLP-1 therapy without navigating insurance pre-authorization
• Prefer the convenience of telehealth over in-person clinic visits
• Have tried diet and exercise alone without achieving sustainable results
• Live in one of the 49 U.S. states where MEDVi operates

MEDVi is not the right choice if you:

• Have a personal or family history of medullary thyroid carcinoma or MEN2 syndrome
• Are pregnant or breastfeeding
• Have a history of pancreatitis
• Are looking for a purely self-directed, no-support prescription service
• Expect results without making any dietary or lifestyle changes

Edge case: Patients with type 2 diabetes who are already on other glucose-lowering medications should disclose this during intake, as GLP-1 medications can interact with insulin and sulfonylureas.

---

How Long Does It Take to See Results With MEDVi

Most patients begin to notice reduced appetite within the first one to two weeks of starting a GLP-1 medication. Visible weight loss typically becomes apparent after four to six weeks, once the medication reaches a therapeutic dose. [6]

Realistic timeline:

• Weeks 1 to 4: Dose titration period. Appetite suppression begins. Some patients experience nausea. Weight loss may be modest (2 to 5 pounds).
• Weeks 4 to 12: Most patients enter a steady loss phase of 1 to 2 pounds per week. [2]
• Months 3 to 6: Cumulative losses of 15 to 30+ pounds are common for adherent patients.
• Months 6 to 12+: Some patients continue losing weight; others shift to maintenance. The Reddit user who used MEDVi for 10 months lost approximately 45 pounds with sustained progress throughout. [1]

Common mistake: Stopping the medication after 4 to 6 weeks because results feel slow. GLP-1 therapy is a gradual process, not a rapid purge. Patients who stay consistent through the titration phase report significantly better outcomes.

---

MEDVi Weight Loss Not Working: Troubleshooting

If you are not seeing results after 8 to 12 weeks on MEDVi, there are several likely explanations and practical fixes.

Most common reasons progress stalls:

• Dosing is still in the titration phase. GLP-1 medications take several weeks to reach effective therapeutic levels. If you are still at a starter dose, results will be limited.
• Dietary habits have not changed. GLP-1 medications reduce hunger but do not eliminate the need for dietary awareness. Patients who continue high-calorie diets often see slower results.
• Medication delivery delays. Some patients report delays in receiving compounded medications, which interrupts dosing consistency. [9] Contact MEDVi’s care team immediately if this happens.
• The medication type may not be optimal for you. Some patients respond better to tirzepatide than semaglutide. Ask your provider about switching if semaglutide is not producing results after 12 weeks.
• Underlying medical conditions. Hypothyroidism, insulin resistance, and certain medications can blunt GLP-1 response. Discuss these with your provider.

What to do: Schedule a virtual check-in with your MEDVi provider. The platform is designed for ongoing communication, and dosing adjustments or medication changes can be made quickly through the telehealth model. [2]

Talk to a MEDVi provider about your progress today.

---

MEDVi Weight Loss Alternatives and Competitors

MEDVi is a strong option, but it is not the only GLP-1 telehealth platform worth considering. Here are the main alternatives and when to choose each.

Direct competitors:

• Hims: Offers compounded semaglutide at competitive pricing with a strong brand reputation. Better for patients who prioritize a well-known consumer brand. See the Hims weight loss review for a full comparison.
• Ro Body: Offers branded and compounded GLP-1 options with a robust app-based support system.
• Noom Med: Combines behavioral coaching with GLP-1 prescriptions, making it a better fit for patients who want intensive habit-change support alongside medication.

Choose MEDVi if: You want a dedicated GLP-1 telehealth program with strong clinical support, broad state availability, and a large base of verified patient reviews.

Choose a competitor if: You prioritize branded medications, want a more app-driven experience, or have specific insurance coverage that works better with another provider.

For a broader look at GLP-1 cost comparisons, see this guide on the least expensive GLP-1 options for weight loss in 2026.

---

Where to Buy MEDVi Weight Loss and Is It Legitimate

MEDVi is a legitimate, licensed telehealth company. It operates through its official website (medvi.org and related domains) and is not sold through third-party retailers or Amazon. [8]

How to verify legitimacy:

• MEDVi has more than 13,000 verified Trustpilot reviews with a 4.4 out of 5 average rating as of May 2026.
• The platform operates in 49 U.S. states with licensed medical providers.
• ConsumerAffairs reviewed MEDVi in October 2026 and confirmed it as a functioning telehealth platform with real clinical staff. [8]

Avoid: Any third-party site claiming to sell “MEDVi medications” independently. Compounded GLP-1 medications must be prescribed by a licensed provider and dispensed by a licensed compounding pharmacy, they cannot be purchased over the counter or from unverified online sellers.

Customer service and refund policy: Some Trustpilot reviewers report difficulty canceling subscriptions and receiving refunds when medication was delayed. [9] If you encounter billing issues, contact MEDVi’s support team directly and document all communications. The platform does have a support process, though response times have drawn criticism from some users.

Visit MEDVi’s official program page to get started.

---

Pros and Cons of MEDVi Weight Loss

Pros	Cons
Strong clinical evidence base for GLP-1 medications	Uses compounded, not FDA-approved branded drugs
4.4/5 stars across 13,000+ Trustpilot reviews	Some billing and cancellation complaints [9]
Ongoing clinical support, not just a prescription	Medication delivery delays reported by some users [9]
No insurance required	Not available in all 50 states
Available in 49 U.S. states [8]	Results require lifestyle changes alongside medication
Documented patient success stories with specific outcomes [3]	Customer service response times can be slow
Both semaglutide and tirzepatide options available	Not suitable for patients with certain thyroid conditions

---

FAQ

How long before I see results with MEDVi?
Most patients notice appetite suppression within 1 to 2 weeks. Meaningful weight loss typically begins at weeks 4 to 6, with 1 to 2 pounds per week being the expected pace during the active phase. [6]

Can I use MEDVi if I have type 2 diabetes?
GLP-1 medications were originally developed for type 2 diabetes management, so many patients with diabetes are good candidates. However, you must disclose all current medications during intake, especially insulin, to avoid hypoglycemia risk.

Is MEDVi’s semaglutide the same as Ozempic or Wegovy?
MEDVi uses compounded semaglutide, which contains the same active ingredient as Ozempic and Wegovy but is not the same FDA-approved finished product. Compounded versions are generally less expensive but are not interchangeable with branded drugs in a regulatory sense.

What if MEDVi is not working for me after 3 months?
Schedule a virtual check-in with your provider. You may need a dose increase, a switch from semaglutide to tirzepatide, or a review of dietary habits. Do not stop the medication without consulting your provider first.

How does MEDVi compare to Hims for weight loss?
Both platforms offer compounded semaglutide without insurance. MEDVi has a larger Trustpilot review base and offers both semaglutide and tirzepatide, while Hims has stronger brand recognition. See the Hims weight loss review for a direct comparison.

Is MEDVi legitimate and safe?
Yes. MEDVi is a licensed telehealth platform with verified patient reviews, licensed medical providers, and clinical oversight. It has more than 13,000 Trustpilot reviews and a 4.4 out of 5 average rating. [4]

Does MEDVi offer tirzepatide as well as semaglutide?
Yes. MEDVi offers both compounded semaglutide and compounded tirzepatide. For more detail, see the MEDVi oral tirzepatide reviews and the MEDVi tirzepatide tablets guide.

What is MEDVi’s refund policy?
MEDVi’s refund policy has drawn some criticism from users who were charged during medication delays. [9] The platform does have a support process for billing disputes, but response times vary. Review the cancellation terms carefully before subscribing.

Can I take MEDVi’s GLP-1 medication if I am pregnant?
No. GLP-1 medications are not recommended during pregnancy or breastfeeding. Disclose pregnancy or plans to become pregnant during your intake consultation.

How do I get started with MEDVi?
Complete MEDVi’s online intake form here to see if you qualify. The process takes approximately 10 to 15 minutes, and a provider will review your case before any prescription is issued.

---

Conclusion

Based on the full body of medvi weight loss reviews, from Trustpilot’s 13,000+ verified ratings to individual Reddit accounts and MEDVi’s own documented success stories, this platform delivers real, measurable results for the majority of patients who follow the program consistently. [1][4] Losses of 40 to 100+ pounds are documented, clinical support is a genuine differentiator, and the GLP-1 medications at the program’s core are among the most evidence-backed weight-loss tools available in 2026.

The program is not perfect. Billing and cancellation processes have frustrated some users, and compounded medications carry different regulatory considerations than branded drugs. But for adults who want medically supervised GLP-1 therapy without insurance barriers, MEDVi represents a credible, accessible, and well-reviewed option.

Your next steps:

1. Determine whether your BMI and health history make you a candidate for GLP-1 therapy.
2. Review the MEDVi tirzepatide monthly cost to understand what you will pay.
3. Start MEDVi’s online intake today to connect with a licensed provider.
4. Read additional MEDVi reviews and complaints to get the full picture before committing.

The evidence is clear: for the right patient, MEDVi’s GLP-1 program works. The question is whether it is the right fit for you.

Find out if MEDVi is right for you, start your intake here.

---

References

[1] Medvi Review After 10 Months Of Use Better Than I – https://www.reddit.com/r/tirzepatidecompound/comments/1lcyorl/medvi_review_after_10_months_of_use_better_than_i/

[2] home.medvi – https://home.medvi.org/

[3] start.medvi – https://start.medvi.org/

[4] Medvi Trustpilot Reviews – https://www.trustpilot.com/review/medvi.org

[5] medvi.ch – https://medvi.ch/

[6] glp1.medvi – https://glp1.medvi.org/

[7] medvi.io – https://medvi.io/

[8] Medvi – ConsumerAffairs – https://www.consumeraffairs.com/health/medvi.html

[9] Medvi Trustpilot Page 9 – https://www.trustpilot.com/review/medvi.org?page=9

[10] Medvi UK Trustpilot Page 10 – https://uk.trustpilot.com/review/medvi.org?page=10

---

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any weight-loss medication or program.

Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you purchase through these links, at no additional cost to you.

---